Cizzle Brands Announces that All 134 Metro Locations in Ontario Will be Offering CWENCH Hydration Ready-to-Drink Beverages

Cizzle Brands Announces that All 134 Metro Locations in Ontario Will be Offering CWENCH Hydration Ready-to-Drink Beverages

The availability of CWENCH Hydration™ in its ready-to-drink format at all 134 Metro locations in Ontario follows only three months after the initial launch of CWENCH's Hydration Mix with Metro in its Ontario stores.

Cizzle Brands Corporation (Cboe Canada: CZZL) (OTCQB: CZZLF) (Frankfurt: 8YF) ( the "Company" or "Cizzle Brands") , is pleased to announce that the ready-to-drink ("RTD") version of the four original flavours of CWENCH Hydration™ (Rainbow Swirl, Blue Raspberry, Cherry Lime, and Berry Crush) are now being carried in all 134 Metro supermarket locations in Ontario. This placement fortifies the presence of CWENCH Hydration™ in key Southern Ontario markets including the Greater Toronto Area, Ottawa, and London, as well as throughout Northern Ontario markets including Sudbury, North Bay, Sault Ste. Marie, and Thunder Bay.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250408602047/en/

The ready-to-drink format of CWENCH Hydration™ is now offered for sale in all 134 Metro locations in Ontario

The ready-to-drink format of CWENCH Hydration™ is now offered for sale in all 134 Metro locations in Ontario

CWENCH Hydration™ is the flagship offering of Cizzle Brands and was first launched in the North American market in late May of 2024. It has since been picked up by over 1,800 points of distribution around the world with double-digit growth across its top North American accounts as of March 2025, and was the primary driving force behind Cizzle Brands' $5.64 million in net sales achieved during the first half of its 2025 fiscal year (as announced in the Company's March 17, 2025 earnings press release).

METRO Inc. is a food and pharmacy leader in Quebec and Ontario, operating a network of 995 food stores (as of December 21, 2024) under several banners including Metro , Metro Plus , Super C , Food Basics , Adonis , and Première Moisson , and 640 pharmacies primarily under the Jean Coutu , Brunet , Metro Pharmacy , and Food Basics Pharmacy banners.

The launch of CWENCH Hydration™ in its RTD format in all Metro Ontario stores follows on from the launch of its Hydration Mix in 47 Metro Ontario stores in January as well as its launch of both RTD and Hydration Mix formats at over 100 stores in Quebec in March.

More information about METRO Inc. and its retail banners can be found on the METRO corporate website: https://corpo.metro.ca/en/home.html

Cizzle Brands' Founder, Chairman, and Chief Executive Officer John Celenza commented, "Our business relationship with METRO Inc. is continuing to grow and drive value, and we are happy to share that the success of CWENCH Hydration™ in Ontario and Quebec has led to broader distribution across Metro banners in both provinces. More and more Canadians of all ages are seeking and asking for CWENCH by name, which means that having the product available across chains such as Metro is an important aspect of gaining market share in the sports drink category. Cizzle Brands is proud to be a supplier to METRO Inc., and we look forward to continuing to work together as part of the growth journey for CWENCH Hydration™."

Charles Buhagiar, Sr. Category Manager of OTC, Health and Wellness for METRO Inc. commented, "The Hydration Mix SKUs of CWENCH Hydration are now available in Metro Ontario grocery and pharmacy stores since being added to planograms at the beginning of this year. We are therefore pleased to continue stocking CWENCH Hydration Mix in addition to the brand's ready-to-drink offerings in our Ontario stores, just in time for the spring and summer seasons when it is all the more important to have a healthy hydration option as well as supporting Canadian brands."

About Cizzle Brands Corporation

Cizzle Brands Corporation is a sports nutrition company that is elevating the game in health and wellness. Through extensive collaboration and testing with leading athletes and trainers across several elite sports, Cizzle Brands has launched two leading product lines in the sports nutrition category: (i) CWENCH Hydration™, a better-for-you sports drink that is now carried in over 1,800 stores in Canada, the United States, and Europe; and (ii) Spoken Nutrition, a premium brand of athlete-grade nutraceuticals that carry the prestigious NSF Certified for Sport® qualification. All Cizzle Brands products are designed to help people achieve their best in both competitive sports and in living a healthy, vibrant, active lifestyle.

For more information about Cizzle Brands, please visit: https://www.cizzlebrands.com/

For more information about CWENCH Hydration™, please visit: https://www.cwenchhydration.com

On behalf of the Board of Directors of the Company,

Cizzle Brands Corporation

"John Celenza"

John Celenza, Founder, Chairman, and Chief Executive Officer

CAUTIONARY NOTE REGARDING FORWARD-LOOKING INFORMATION

This news release contains "forward-looking information" which may include, but is not limited to, information with respect to the activities, events or developments that the Company expects or anticipates will or may occur in the future, such as, but not limited to: new products of the Company and potential sales and distribution opportunities. Such forward-looking information is often, but not always, identified by the use of words and phrases such as "plans", "expects", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates", or "believes" or variations (including negative variations) of such words and phrases, or state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. Various assumptions or factors are typically applied in drawing conclusions or making the forecasts or projections set out in forward-looking information. Those assumptions and factors are based on information currently available to the Company.

Forward looking information involves known and unknown risks, uncertainties and other risk factors which may cause the actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information. Such risks include risks related to increased competition and current global financial conditions, access and supply risks, reliance on key personnel, operational risks, regulatory risks, financing, capitalization and liquidity risks. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking information. The Company undertakes no obligation, except as otherwise required by law, to update these forward-looking statements if management's beliefs, estimates or opinions, or other factors change.

For further information, please contact:

Setti Coscarella
Head of Corporate Development
investors@cizzlebrands.com
1-844-588-2088

News Provided by Business Wire via QuoteMedia

CZZL:AQL
The Conversation (0)
Cizzle Brands Corporation (CBOE:CZZL)

Cizzle Brands Corporation

A Sports Nutrition Company Leading the Next Wave in Health and Wellness

A Sports Nutrition Company Leading the Next Wave in Health and Wellness Keep Reading...
Microscope and syringe overlay a digital stock chart with green lines and numbers.

Kailera, Alamar Target Billion-Dollar Valuations in Biotech Revival

Biotechnology initial public offerings (IPOs) are regaining momentum as easing market headwinds and an appetite for weight-loss drugs coax companies back to the public markets.On Monday (April 13) Reuters reported, that obesity drug developer Kailera Therapeutics and proteomics firm Alamar... Keep Reading...
Transparent blue cells with dark centers floating against a vibrant blue background.

Biotech and Pharma Market Update: Q1 2026 in Review

After a strong performance toward the end of 2025, the life science sector began the new year on a constructive note; however, signals in Q1 point to a market continuing to reward proof over promise. In an interview with the Investing News Network (INN), Eric Shrayer, partner and director of... Keep Reading...
A glass flask on a reflective table with overlaid stock market charts and numerical data, including text reading: 0.00%.

Anthropic Inks US$400 Million Deal for AI Biotech Startup Coefficient Bio

AI developer Anthropic is acquiring New York-based biotech startup Coefficient Bio for approximately US$400 million, according to The Information.Founded just last fall and operating largely in stealth, Coefficient Bio will be absorbed directly into Anthropic’s healthcare life sciences... Keep Reading...
Lexaria Applauds Eli Lilly's Foundayo Drug Approval

Lexaria Applauds Eli Lilly's Foundayo Drug Approval

The number of oral weight-loss / diabetes drug treatments is expanding, increasing demand for the reduction of side effects KELOWNA, BC / ACCESS Newswire / April 7, 2026 / Lexaria Bioscience Corp. (Nasdaq:LEXX), (the "Company" or "Lexaria"), a global innovator in drug delivery platforms is... Keep Reading...
Lexaria Applauds Eli Lilly's Foundayo Drug Approval

Lexaria Applauds Eli Lilly's Foundayo Drug Approval

The number of oral weight-loss / diabetes drug treatments is expanding, increasing demand for the reduction of side effects KELOWNA, BC / ACCESS Newswire / April 7, 2026 / Lexaria Bioscience Corp. (Nasdaq:LEXX), (the "Company" or "Lexaria"), a global innovator in drug delivery platforms is... Keep Reading...
Cardiol Therapeutics to Present at TD Cowen 46th Annual Health Care Conference

Cardiol Therapeutics to Present at TD Cowen 46th Annual Health Care Conference

Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a late-stage life sciences company focused on advancing the development of anti-inflammatory and anti-fibrotic therapies for heart disease, is pleased to announce that it will participate at the upcoming TD Cowen... Keep Reading...

Interactive Chart

Latest Press Releases

Related News